Use of BUBR1 as a biomarker of drug response to furazanobenzimidazoles

摘要

Use of BUBR1 as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject, wherein the compound is a furazanobenzimidazole compound of general formula (I).